These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. Naserke HE; Ziegler AG; Lampasona V; Bonifacio E J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731 [TBL] [Abstract][Full Text] [Related]
24. Recent advances in immunology of Type 1 diabetes mellitus: a congenital disorder? Bruining GJ; Batstra MR Diabetes Nutr Metab; 1999 Apr; 12(2):68-74. PubMed ID: 10554889 [No Abstract] [Full Text] [Related]
25. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes]. Bieg S; Seissler J; Scherbaum WA Med Klin (Munich); 1995 Oct; 90(10):594-8. PubMed ID: 7500923 [No Abstract] [Full Text] [Related]
26. Study of islet cell antibodies as predictive marker of type 1 diabetes. Mitrea MC; Cojocaru M Rom J Intern Med; 1998; 36(3-4):261-5. PubMed ID: 10822523 [TBL] [Abstract][Full Text] [Related]
27. Is there a relationship between islet cell surface antibodies and clinical, biochemical, hormonal, and immunogenetic parameters in newly diagnosed type I diabetics? Michaelis D; Rjasanowski I; Ratzmann KP; Strese J; Dietz H; Hildmann W Acta Biol Med Ger; 1982; 41(12):1093-8. PubMed ID: 6765149 [No Abstract] [Full Text] [Related]
28. [Etiology and pathogenesis of type I diabetes]. Ziegler AG Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631 [TBL] [Abstract][Full Text] [Related]
29. [Autoantibodies in the pathogenesis and diagnosis of insulin-dependent diabetes mellitus]. Prázný M; Skrha J Cas Lek Cesk; 1999 Apr; 138(9):268-71. PubMed ID: 10422334 [TBL] [Abstract][Full Text] [Related]
30. [Role of autoimmune processes in the pathogenesis of diabetes mellitus]. Sil'nitskiĭ PA; Shabanova LF Klin Med (Mosk); 1980 Oct; 58(10):22-6. PubMed ID: 7003240 [No Abstract] [Full Text] [Related]
31. Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes. Gilliam LK; Brooks-Worrell BM; Palmer JP; Greenbaum CJ; Pihoker C J Autoimmun; 2005 Nov; 25(3):244-50. PubMed ID: 16243484 [TBL] [Abstract][Full Text] [Related]
32. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin]. Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176 [TBL] [Abstract][Full Text] [Related]
33. [Prevalence of islet cell antibodies among 1021 relatives of type 1 diabetics]. Maiz A; Manrique M; Hodgson MI; Díaz de Valdés M; Acosta AM; Andrade L; Olmos P Rev Med Chil; 1999 May; 127(5):515-22. PubMed ID: 10451620 [TBL] [Abstract][Full Text] [Related]
35. Islet autoimmunity and genetic mutations in Chinese subjects initially thought to have Type 1B diabetes. Zhang D; Zhou Z; Li L; Weng J; Huang G; Jing P; Zhang C; Peng J; Xiu L Diabet Med; 2006 Jan; 23(1):67-71. PubMed ID: 16409568 [TBL] [Abstract][Full Text] [Related]
36. [Autoantibodies in type 1 diabetes mellitus]. Ziegler M; Ziegler B Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261 [No Abstract] [Full Text] [Related]
37. The INS B allele (1,428 Fok I) is associated with reduced IDDM incidence in autoantibody-positive first degree relatives despite the presence of autoantibodies and high-risk HLA alleles. Pugliese A; Awdeh ZL; Alper CA; Jackson RA; Eisenbarth GS Transplant Proc; 1995 Dec; 27(6):3392. PubMed ID: 8540014 [No Abstract] [Full Text] [Related]
38. [Differential diagnosis of diabetes mellitus in adults: assessment of immunogenetic markers of insulin dependence]. Turiev GS; Ametov AS; Kondrat'ev IaIu; Timofeev AV Klin Med (Mosk); 2004; 82(1):47-52. PubMed ID: 15022597 [TBL] [Abstract][Full Text] [Related]